Moyamoya Syndrome With Intraventricular Hemorrhage in an Adult With Factor V Leiden Mutation | Cerebrovascular Disease | JAMA Neurology | JAMA Network
[Skip to Navigation]
Sign In
July 2005

Moyamoya Syndrome With Intraventricular Hemorrhage in an Adult With Factor V Leiden Mutation

Author Affiliations

Author Affiliations: Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Arch Neurol. 2005;62(7):1144-1146. doi:10.1001/archneur.62.7.1144

Objective  To report a case of proximal occlusion of 2 major cerebral vessels associated with moyamoya network circulation that manifested by spontaneous intraventricular hemorrhage.

Design  Case report.

Patient and Results  A 36-year-old Syrian man presented with symptoms of sudden-onset headache, neck stiffness, and confusion. The computed tomography scan of his brain showed intraventricular bleeding, and the subsequent 4 vessel angiographies revealed occlusion of the left middle and anterior cerebral arteries with moyamoya appearance in the terminal branches. The coagulation profile showed the presence of heterozygous factor V Leiden mutation. The patient was treated conservatively until resolution of his blood clot, and later he was started on oral anticoagulation.

Conclusion  Factor V Leiden mutation may cause large cerebral vessel occlusion with moyamoya syndrome in adults.

Factor V Leiden mutation that is associated with resistance to activated protein C is a risk marker for venous and arterial thrombosis.1 Although individuals with factor V Leiden mutation showed a trend toward a higher frequency of central nervous system thrombosis in premature neonates,2,3 infants, and children4 as well as in young adults,5,6 this complication was not found in older age groups. Furthermore, factor V Leiden mutation may predispose to large brain infarcts.7 In addition, heterozygosity for factor V Leiden mutation seems to increase the risk of stroke in children by almost 5-fold.8,9

Stenotic disease of large cerebral vessels due to atherothrombotic lesion may lead to the development of moyamoya-type collateral circulation and may present as intracerebral hemorrhage.10 Herein we report a case of large vessel occlusion associated with heterozygous factor V Leiden mutation and complicated by moyamoya appearance on cerebral angiographies, manifesting with intraventricular hemorrhage in a middle-age patient.

Report of a case

A 36-year-old, Syrian, nonhypertensive man was referred to our facility at the American University of Beirut Medical Center (Beirut, Lebanon) for evaluation and further management of an intraventricular hemorrhage. In March 2002, the patient developed sudden onset of severe global headache associated with nausea and projectile vomiting. His past medical illness was negative except for smoking and a positive family history of coronary artery disease. The physical examination upon admission to our hospital 1 week later revealed a low-grade fever (38°C) and meningeal signs, with confusion and agitation; otherwise, the physical examination findings were normal. A computed tomography scan of the brain done prior to admission showed an intraventricular hemorrhage involving the lateral and third ventricles (Figure 1). Four vessel cerebral angiographies performed under fluoroscopic control and through a right femoral artery approach showed total occlusion of the anterior and middle cerebral arteries at their proximal portions on the left side. The terminal branches of the occluded vessels were filling from collaterals derived from the posterior circulation and thalamic branches, giving the angiographic appearance of moyamoya vessels (Figure 2B). The right anterior, middle, and posterior cerebral arteries were patent (Figure 2A). The aortic and extracranial vessels in the neck showed no other stenotic lesions.

Figure 1. 
Computed tomography scan of brain showing the intraventricular hemorrhage.

Computed tomography scan of brain showing the intraventricular hemorrhage.

Figure 2. 
A, Right internal carotid angiogram showing patent anterior, middle, and posterior cerebral vessels. B, Left internal carotid angiogram showing the occlusion of the proximal part of the left anterior (white arrow with border) and middle cerebral arteries (white arrow) and the moyamoya vessels in the region of the basal ganglia and thalamus (black arrow).

A, Right internal carotid angiogram showing patent anterior, middle, and posterior cerebral vessels. B, Left internal carotid angiogram showing the occlusion of the proximal part of the left anterior (white arrow with border) and middle cerebral arteries (white arrow) and the moyamoya vessels in the region of the basal ganglia and thalamus (black arrow).

Laboratory tests revealed normal blood cell counts, blood urea nitrogen levels, creatinine levels, electrolyte levels, and liver function tests. The erythrocyte sedimentation rate was 16 mm/h. The fibrinogen level was 5.1 g/L (normal range, 2-5 g/L). The C3 level was 1.17 g/L (normal range, 0.9-1.8 g/L), and the C4 level was 0.21 g/L (normal range, 0.1-0.4 g/L). A test for antinuclear antibodies was negative. Serological tests for brucella, Venereal Disease Research Laboratory (VDRL; syphilis), and hepatitis B surface antigen (HbsAg) were all negative. A test for purified protein derivative (PPD) was negative. The coagulation profile showed the following values: partial thromboplastin time, 31 seconds (patient) and 30.5 seconds (control subject); international normalized ratio, 0.95; protein S level, 64% (normal range, 59%-187%); protein C level, 86.3% (normal range, 70%-130%); antithrombin III level, 100% (normal range, 73%-130%); homocysteine level, 8.8 μg/mL (normal range, 5-15 μg/mL). Hemoglobin electrophoresis was consistent with heterozygous thalassemia and no sickle hemoglobin. A test for lupus anticoagulant was negative; tests for anticardiolipin antibodies were weakly positive (immunoglobulin G, 18 g/L; immunoglobulin M test, negative). Test results for mutation C677T of the methylenetetrahydrofolate reductase gene and mutation G20210 of the prothrombin gene (factor II) were negative. The patient had positive test results for a heterozygous mutation of factor V Leiden. The chest x-ray and urinalysis results were normal.

The patient was treated conservatively with sedation and fluid hydration. His neurological status and mentation improved gradually, and he was discharged after full neurological recovery. After his condition was stabilized, the patient was started on oral anticoagulation treatment.


Resistance to activated protein C (APC) degradation is caused by a specific point mutation in the factor V gene in which arginine 506 is replaced by glutamine.

Factor V Leiden mutation has the highest prevalence rate in the Eastern Mediterranean in apparently healthy individuals, and it is estimated to be 13.6% in Syria.11-13Our patient belongs to a population with prevalent factor V Leiden mutation and appeared to be a carrier of the heterozygous gene. He suffered from an intraventricular hemorrhage with a large cerebral vessel occlusion and abnormal moyamoya-type collateral circulation. Moyamoya is a Japanese term meaning “hazy puff of smoke,” and the syndrome is defined as a combination of an occlusion of the large cerebral vessels either intracranially or extracranially and the angiographic appearance of telangiectatic collateral vessels.14 Many sporadic case reports of the occurrence of spontaneous large cerebral artery occlusion and intracerebral bleeding with moyamoya appearance have been described in the literature.15-17 The initial presentation is caused either by cerebral ischemia or intracerebral hemorrhages. The etiology of the hemorrhage is thought to be aneurysmal formation or dilated collaterals in the territory of these telangiectatic vessels that will rupture secondary to hemodynamic changes at a later stage. Few reported cases presented with intraventricular hemorrhage.18 In these cases and in ours, the intraventricular hemorrhage was assumed to be caused by the rupture of these ectatic dilated vessels running in the subependyma of the ventricle. Conditions that may lead to cerebral vessel occlusion with moyamoya vascularization include antiphospholipid syndrome,17 sickle cell disease,19 and atherothrombosis.10

Herein, we report a patient as being the first case, to our knowledge, of intraventricular hemorrhage due to moyamoya collateral circulation caused by an occlusion of the proximal portions of the anterior and middle cerebral arteries, assumed to be secondary to a heterozygous factor V Leiden mutation. It is recommended that physicians check for factor V Leiden in patients from the Eastern Mediterranean region who have cerebrovascular disease and moyamoya collateral vessels.

Back to top
Article Information

Correspondence: Rosette Jabbour, MD, American University of Beirut Medical Center, PO Box 113-6044, Hamra 110 32090, Beirut, Lebanon ( or

Accepted for Publication: April 28, 2004.

Author Contributions:Study concept and design: Jabbour. Acquisition of data: Jabbour, Taher, and Atweh. Analysis and interpretation of data: Jabbour, Shamseddine, and Atweh. Drafting of the manuscript: Jabbour, Taher, and Atweh. Critical revision of the manuscript for important intellectual content: Atweh, Taher, and Shamseddine.

Bertina  RMKoeleman  BPKoster  T  et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C.  Nature 1994;36964- 67PubMedGoogle ScholarCrossref
Aronis  SBouza  HPergantou  HKapsimalis  ZPlatokouki  HXanthou  M Prothrombotic factors in neonates with cerebral thrombosis and intraventricular hemorrhage.  Acta Paediatr Suppl 2002;9187- 91PubMedGoogle ScholarCrossref
Varelas  PNSleight  BJRinder  HMSze  GMent  LR Stroke in a neonate heterozygous for factor V Leiden.  Pediatr Neurol 1998;18262- 264PubMedGoogle ScholarCrossref
Lynch  JKNelson  KBCurry  CJGrether  JK Cerebrovascular disorders in children with the factor V Leiden mutation.  J Child Neurol 2001;16735- 744PubMedGoogle ScholarCrossref
Marinella  MAGreene  K Bilateral thalamic infarction in a patient with Factor V Leiden mutation.  Mayo Clin Proc 1999;74795- 797PubMedGoogle ScholarCrossref
Orlandi  GPellegrinetti  AFioretti  CMartini  AMurri  L Factor V Leiden mutation in a case with ischemic stroke: which relationship? A case report.  Angiology 1998;4979- 82PubMedGoogle ScholarCrossref
Szolnoki  ZSomogyvari  FKondacs  ASzabo  MFodor  L Evaluation of the roles of the factor V Leiden mutation and ACE I/D polymorphism in subtypes of ischaemic stroke.  J Neurol 2001;248756- 761PubMedGoogle ScholarCrossref
Steiner  MHodes  MZScreve  MSundberg  SEdson  JR Postoperative stroke in a child with cerebral palsy heterozygous for factor V Leiden.  J Pediatr Hematol Oncol 2000;22262- 264PubMedGoogle ScholarCrossref
Kenet  GSadetzki  SMurad  H  et al.  Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.  Stroke 2000;311283- 1288PubMedGoogle ScholarCrossref
Masson  CMartin  NMasson  MCambier  J Intraventricular hemorrhage after carotid endarterectomy: role of moyamoya-type collateral circulation [in French].  Rev Neurol (Paris) 1986;142716- 719PubMedGoogle Scholar
Irani-Hakime  NTamim  HKreidy  RAlmawi  WY The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese.  Am J Hematol 2000;6545- 49PubMedGoogle ScholarCrossref
Irani-Hakime  NTamim  HElias  GFinan  RRDaccache  JLAlmawi  WY High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean [letter].  Clin Chem 2000;46134- 136PubMedGoogle Scholar
Taher  AKhalil  IShamseddine  AEl-Ahdab  FBazarbachi  A High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation? [letter].  Thromb Haemost 2001;86723- 724PubMedGoogle Scholar
Suzuki  JKodama  N Moyamoya disease: a review.  Stroke 1983;14104- 109PubMedGoogle ScholarCrossref
Kageji  TMurayama  YMatsumoto  K Spontaneous middle cerebral artery occlusion with moyamoya-like vessels associated with contralateral middle cerebral artery aneurysm: a case report.  No Shinkei Geka 1992;20177- 181PubMedGoogle Scholar
Seki  YFujita  MMizutani  NKimura  MSuzuki  Y Spontaneous middle cerebral artery occlusion leading to moyamoya phenomenon and aneurysm formation on collateral arteries.  Surg Neurol 2001;5558- 62PubMedGoogle ScholarCrossref
Inoue  RKatayama  SKasai  NHori  S Middle cerebral artery occlusion with unilateral moyamoya like vessels and with rupture anterior cerebral artery aneurysm: its relation to the antiphospholipid antibody syndrome.  No To Shinkei 1994;46995- 998PubMedGoogle Scholar
Sato  MKohama  AFukuda  ATanaka  SFukunaga  MMorita  R Moyamoya-like diseases associated with intraventricular hemorrhages: report of three cases.  Neurosurgery 1985;17260- 266PubMedGoogle ScholarCrossref
Dobson  SRHolden  KRNietert  PJ  et al.  Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.  Blood 2002;993144- 3150PubMedGoogle ScholarCrossref